The global live cell imaging market size was estimated to be USD 2.74 billion in 2023 and is expected to reach USD 7.11 billion by 2034 with a CAGR of 9.06% during the forecast period 2024-2034. The market will grow due to technological advancements, increased cell biology research, an increase in the prevalence of chronic diseases, and a rising desire for personalized medication.
The emergence of advanced imaging technologies, including high-content screening (HCS), fluorescence resonance energy transfer (FRET), and super-resolution microscopy, has significantly transformed the field of live cell imaging. These innovations enable precise real-time monitoring of cellular processes, thereby enhancing research capabilities in drug discovery, cell biology, and disease modeling. Furthermore, the integration of artificial intelligence (AI) and machine learning (ML) into image analysis is propelling the field forward, providing deeper insights into complex cellular behaviors. A prime example of this advancement is Thrive Bioscience’s CellAssist Software Release 5.0, which was showcased at Cell Bio 2023. Scheduled for beta release in mid-2024, this software offers cutting-edge features for live cell imaging and data analysis, aiming to accelerate research through improved image processing and AI-driven insights. Such technological advancements serve as critical drivers of the global live cell imaging market, fostering growth and expanding applications across the biotechnology and pharmaceutical industries.
By product, the equipment segment accounted for the highest revenue-grossing segment in the global live cell imaging market in 2023 owing to the increasing adoption of advanced imaging technologies and continuous innovations in microscopy and imaging systems. For instance, in February 2023, Nikon Corporation developed the Nikon Spatial Array Confocal (NSPARC) detector for AXE systems. This detector enables for high-resolution imaging of live tissue with minimal phototoxicity. Additionally, the consumable segment is predicted to grow at the fastest CAGR during the forecast period owing to the rising demand for reagents, assay kits, and media used in live cell imaging experiments.
By application, the stem cell & drug discovery segment accounted for the highest revenue-grossing segment in the global live cell imaging market in 2023 owing to the increasing use of live cell imaging in stem cell research and its critical role in accelerating drug discovery and development. For instance, in January 2023, Bruker Corporation announced the acquisition of ACQUIFER Imaging GmbH, a leader in big-data management solutions for bioimaging and high-content microscopy. This acquisition offers high-performance on-premise processing, secure storage, and networking technology to Bruker's advanced fluorescence microscopy imaging solutions, such as light-sheet and super-resolution microscopy, which create large amounts of information. Additionally, the developmental biology segment is predicted to grow at the fastest CAGR during the forecast period owing to the growing need to study cellular processes in real-time for understanding organismal development and disease progression.
By technology, the high content screening (HCS) segment accounted for the highest revenue-grossing segment in the global live cell imaging market in 2023 owing to the increasing demand for automated imaging and analysis in drug discovery and cell biology research. For instance, in June 2023, Nanolive announced the 3D Cell Explorer 96focus, a one-of-a-kind platform that allows for label-free live cell imaging and unlimited high-content analysis. The 3D Cell Explorer 96focus simplifies the imaging procedure with AI-powered digital assays and an automated workflow, giving researchers a cost-effective and dependable way to conduct cell imaging studies. Additionally, the time-lapse microscopy segment is predicted to grow at the fastest CAGR during the forecast period owing to the rising demand for real-time monitoring of dynamic cellular processes over extended periods.
By end-user, the pharmaceutical and biotechnological companies segment accounted for the highest revenue-grossing segment in the global live cell imaging market in 2023 owing to the extensive use of live cell imaging in drug discovery, development, and testing of new therapies. For instance, in January 2023, Biognosys and Bruker partnered to offer advanced proteomics CRO services to global biopharma and biomarker customers. This collaboration intends to increase access to Biognosys' CRO services and Spectronaut® software tools, enabling more objective proteomics and epiproteomics research. Additionally, the contract research organizations (CROs) segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing outsourcing of research and drug development activities by pharmaceutical and biotech companies.
North American region is anticipated for the highest revenue share during the forecast period owing to the presence of leading biotechnology and pharmaceutical companies, robust research funding, and advanced healthcare infrastructure. Additionally, the Asia Pacific region is predicted to grow at the fastest CAGR during the forecast period owing to the increasing investment in healthcare research, rising demand for advanced imaging technologies, and growing biopharmaceutical industries. For instance, BD introduced BD CellViewTM Image Technology in August 2023, which is integrated into their cell sorting devices. Thanks to this advancement, scientists can now view and categorize live cells in real time according to their visual properties. Through the use of full-spectrum technology, the system improves cellular detail and offers more insights into the activity and function of cells during live cell research.
This comprehensive research report focuses on the global and regional market size and forecasts from 2023 to 2034.
The emergence of advanced imaging technologies, including high-content screening (HCS), fluorescence resonance energy transfer (FRET), and super-resolution microscopy, has significantly transformed the field of live cell imaging. These innovations enable precise real-time monitoring of cellular processes, thereby enhancing research capabilities in drug discovery, cell biology, and disease modeling. Furthermore, the integration of artificial intelligence (AI) and machine learning (ML) into image analysis is propelling the field forward, providing deeper insights into complex cellular behaviors. A prime example of this advancement is Thrive Bioscience’s CellAssist Software Release 5.0, which was showcased at Cell Bio 2023. Scheduled for beta release in mid-2024, this software offers cutting-edge features for live cell imaging and data analysis, aiming to accelerate research through improved image processing and AI-driven insights. Such technological advancements serve as critical drivers of the global live cell imaging market, fostering growth and expanding applications across the biotechnology and pharmaceutical industries.
By product, the equipment segment accounted for the highest revenue-grossing segment in the global live cell imaging market in 2023 owing to the increasing adoption of advanced imaging technologies and continuous innovations in microscopy and imaging systems. For instance, in February 2023, Nikon Corporation developed the Nikon Spatial Array Confocal (NSPARC) detector for AXE systems. This detector enables for high-resolution imaging of live tissue with minimal phototoxicity. Additionally, the consumable segment is predicted to grow at the fastest CAGR during the forecast period owing to the rising demand for reagents, assay kits, and media used in live cell imaging experiments.
By application, the stem cell & drug discovery segment accounted for the highest revenue-grossing segment in the global live cell imaging market in 2023 owing to the increasing use of live cell imaging in stem cell research and its critical role in accelerating drug discovery and development. For instance, in January 2023, Bruker Corporation announced the acquisition of ACQUIFER Imaging GmbH, a leader in big-data management solutions for bioimaging and high-content microscopy. This acquisition offers high-performance on-premise processing, secure storage, and networking technology to Bruker's advanced fluorescence microscopy imaging solutions, such as light-sheet and super-resolution microscopy, which create large amounts of information. Additionally, the developmental biology segment is predicted to grow at the fastest CAGR during the forecast period owing to the growing need to study cellular processes in real-time for understanding organismal development and disease progression.
By technology, the high content screening (HCS) segment accounted for the highest revenue-grossing segment in the global live cell imaging market in 2023 owing to the increasing demand for automated imaging and analysis in drug discovery and cell biology research. For instance, in June 2023, Nanolive announced the 3D Cell Explorer 96focus, a one-of-a-kind platform that allows for label-free live cell imaging and unlimited high-content analysis. The 3D Cell Explorer 96focus simplifies the imaging procedure with AI-powered digital assays and an automated workflow, giving researchers a cost-effective and dependable way to conduct cell imaging studies. Additionally, the time-lapse microscopy segment is predicted to grow at the fastest CAGR during the forecast period owing to the rising demand for real-time monitoring of dynamic cellular processes over extended periods.
By end-user, the pharmaceutical and biotechnological companies segment accounted for the highest revenue-grossing segment in the global live cell imaging market in 2023 owing to the extensive use of live cell imaging in drug discovery, development, and testing of new therapies. For instance, in January 2023, Biognosys and Bruker partnered to offer advanced proteomics CRO services to global biopharma and biomarker customers. This collaboration intends to increase access to Biognosys' CRO services and Spectronaut® software tools, enabling more objective proteomics and epiproteomics research. Additionally, the contract research organizations (CROs) segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing outsourcing of research and drug development activities by pharmaceutical and biotech companies.
North American region is anticipated for the highest revenue share during the forecast period owing to the presence of leading biotechnology and pharmaceutical companies, robust research funding, and advanced healthcare infrastructure. Additionally, the Asia Pacific region is predicted to grow at the fastest CAGR during the forecast period owing to the increasing investment in healthcare research, rising demand for advanced imaging technologies, and growing biopharmaceutical industries. For instance, BD introduced BD CellViewTM Image Technology in August 2023, which is integrated into their cell sorting devices. Thanks to this advancement, scientists can now view and categorize live cells in real time according to their visual properties. Through the use of full-spectrum technology, the system improves cellular detail and offers more insights into the activity and function of cells during live cell research.
This comprehensive research report focuses on the global and regional market size and forecasts from 2023 to 2034.
Report Scope:
- Base Year: 2023
- Forecast Period: 2024-2034
- Study Coverage
- Market Forecast by Product, Application, Technology, and End-User
- Market Forecast for 5 Regions and 17+ Countries
- North America (U.S. and Canada)
- Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
- Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
- Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
- MEA (South Africa, GCC, Rest of MEA)
- Exhaustive Company Profiles of the Top 10+ Major Market Players
- 20% Free Customization Available to Meet Your Exact Requirement.
Segmentation: Live Cell Imaging Market Report 2023 - 2034
Live Cell Imaging Market Analysis & Forecast by Product 2023 - 2034 (Revenue USD Bn)
- Equipment
- Consumable
- Software
Live Cell Imaging Market Analysis & Forecast by Application 2023 - 2034 (Revenue USD Bn)
- Cell Biology
- Developmental Biology
- Stem Cell & Drug Discovery
- Others
Live Cell Imaging Market Analysis & Forecast by Technology 2023 - 2034 (Revenue USD Bn)
- Time-Lapse Microscopy
- Fluorescence Recovery After Photobleaching (FRAP)
- Fluorescence Resonance Energy Transfer (FRET)
- High Content Screening (HCS)
- Others
Live Cell Imaging Market Analysis & Forecast by End-User 2023 - 2034 (Revenue USD Bn)
- Pharmaceutical and Biotechnological Companies
- Academic and Research Institutes
- Contract Research Organizations
- Others
Live Cell Imaging Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Live Cell Imaging Market: Product and Services Estimates & Trend Analysis
8. Live Cell Imaging Market: Application Estimates & Trend Analysis
9. Live Cell Imaging Market: Technology Estimates & Trend Analysis
10. Live Cell Imaging Market: End-User Estimates & Trend Analysis
11. Regional Market Analysis
12. North America Live Cell Imaging Market
13. Europe Global Live Cell Imaging Market
14. Asia Pacific Global Live Cell Imaging Market
15. Latin America Global Live Cell Imaging Market
16. MEA Global Live Cell Imaging Market
17. Competitor Analysis
18. Company Profiles
Companies Mentioned
- Carl Zeiss AG
- Leica Microsystems (Danaher Corporation)
- Olympus Corporation
- Nikon Corporation
- Thermo Fisher Scientific Inc.
- PerkinElmer Inc.
- Merck KGaA (MilliporeSigma)
- Bio-Rad Laboratories Inc.
- Becton
- Dickinson
- and Company (BD)
- GE Healthcare
- Cell Signaling Technology Inc.
- Hamamatsu Photonics K.K.
- Andor Technology (Oxford Instruments)
- Sutter Instrument Company
- Molecular Devices LLC.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | December 2024 |
| Forecast Period | 2023 - 2034 |
| Estimated Market Value ( USD | $ 2.74 Billion |
| Forecasted Market Value ( USD | $ 7.11 Billion |
| Compound Annual Growth Rate | 9.0% |
| Regions Covered | Global |
| No. of Companies Mentioned | 17 |
